Navigation Links
Cardium Presents Year-End 2012 Financial Results And Recent Developments
Date:4/5/2013

mpany's Generx clinical development program;
  • Favorable patent decision in Europe and successful resolution of a long standing competition between Cardium and its licensor, the University of California, and Boston Scientific Corporation and its licensor, Arch Development, over the rights to key methods for the application of cardiovascular gene therapy in the treatment of coronary heart disease, as is employed in the Company's Generx gene therapy candidate.
  • Health Sciences Business and Other Strategic
    Partnered-Enabled Product Initiatives

  • Acquired To Go Brands® nutraceutical supplement brand platform with over 25 products being developed and sold through established regional and national food, drug and mass channel retailers at over 10,000 retail locations to expand and broaden Cardium's Health Sciences Business;
  • Announced expansion of the To Go Brands VitaRocks® Kids vitamin products and retail distribution of the newly-designed VitaRocks product line into select Target stores nationwide;
  • Reported plans for the partner-enabled clinical development of Genedexa™ (previously referred to as the Excellarate™ product candidate), a DNA-based Phase 2b/3 product candidate initially for the treatment of chronic, non-healing diabetic foot ulcers and representing the first product extension from the Company's FDA-cleared Excellagen technology platform;
  • Developed a new in-house partner-enabled product opportunity, LifeAgain™, a medical analytics and e-commerce platform of algorithms and medical-based programs that were developed by Cardium researchers to support a strategically partnered commercialization of specialized survivable risk life insurance underwritings for cancer patients and patients with chronic medical diseases, based on the improvement of early diagnosis and new chronic treatments and cura
    '/>"/>

  • SOURCE Cardium Therapeutics
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Cardium Announces $4.0 Million Preferred Stock Financing And Reports On Exchange Listing Compliance
    2. Cardium Receives ISO Certification for Excellagen
    3. Cardium Announces Presentaton at The 2013 Cell & Gene Therapy Forum
    4. Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
    5. Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference
    6. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
    7. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
    8. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
    9. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
    10. Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care
    11. Pharmagen Presents to North Carolina General Assembly at N.C. Bios Legislative Breakfast
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... Biotherapeutics, Inc. (NASDAQ: NWBO )("NW Bio"), a U.S. ... inoperable solid tumor cancers, announced today that CEO Linda ... Phacilitate Immunotherapy Forum in Washington D.C. ... on January 26 at 10:30 a.m. EST at the Grand ...
    (Date:1/23/2015)... /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is investigating potential ... ("Advaxis" or the "Company") (NASDAQ: ADXS ), ... to shareholders. On January 21, 2015, an ... Advaxis had misrepresented the clinical data for its ADXS-HPV ...
    (Date:1/23/2015)... Inc. (ICBU) has repositioned itself as a holding company with ... in the hydroponic, hemp and medical marijuana sectors. By acquiring ... sector, and recently partnering with the Chippewa Tribe Nation to ... iMD is committing to bring its vision to the market ...
    Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
    ... Coulter, Inc. (NYSE: BEC ) a leading developer, manufacturer ... biomedical testing previously announced it will host a conference call ... discuss the company,s third quarter 2009 results. In addition ... of accompanying slides accessible on the company,s website. , ...
    ... , MOUNTAIN VIEW, Calif., Oct. 29 VIVUS, Inc. ... on Qnexa(TM), an investigational drug candidate for obesity, was ... Obesity Society (TOS) in Washington D.C. Wesley W. ... presented the additional data from the company,s two year-long ...
    Cached Medicine Technology:Beckman Coulter Announces Conference Call and Webcast of Accompanying Slides in Conjunction With Third Quarter 2009 Earnings 2Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 2Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 3Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 4Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 6Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 7Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 8
    (Date:1/22/2015)... PA (PRWEB) January 22, 2015 Woodloch Pines, ... Mountains, has been selected by TripAdvisor as the number one ... the 6th best in the world for their annual Travelers’ ... online travel community . The website is home to millions ...
    (Date:1/22/2015)... The Incredible Bulk is a revolutionary method put ... muscle by up to 30lbs in less than 12 weeks ... Stan Stevenson, prompting an investigative review. , “Our Incredible ... diet formula that allows the body to pack on a ...
    (Date:1/22/2015)... New York (PRWEB) January 22, 2015 The ... ) in the U.S. District Court, Southern District of West ... Bard, Inc. in that proceeding’s first bellwether trial. In an ... for a new trial after finding that C.R. Bard had ...
    (Date:1/22/2015)... has released a new blog post explaining the main features ... , Auto insurance quotes help many drivers find the best ... call an agent or visit an agency for price information. ... http://autocarinsurancebest.com/ . , Every business who relies heavily on ...
    (Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
    Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
    ... a tattoo done of their lover's initials due to fear ... news - researchers have discovered a technique, where the cryptic ... wearer's choice. ,The new method is called micro-encapsulation, ... microcapsules, that are as tiny as pins, can bear a ...
    ... skin cancer many people still disregard the use of sunscreen to ... that one in three Briton do not protect their skin ... skin cancer are diagnosed in the UK each year, and recent ... in the next 30 years. ,Research by the ...
    ... on controlling immune system responses, announced the acquisition ... in organ transplantation. ,Circassia acquired the ... of Birmingham in the UK for an undisclosed ... on product sales. Scientifically, the ToleroTrans approach mirrors ...
    ... Hundreds of cyclists will be participating in the Memory Ride ... raising money to fight the disease that affects more ... in the 11th annual Memory Ride has a personal story ... family friend who has struggled with the disease. ...
    ... revolution this weekend when a fleet of 10,000 self-service bicycles hits ... metro for Parisians and tourists alike. ,As the Tour ... country, in Paris amateur cyclists will from Sunday be able to ... for short trips, dropping them off at any of 750 bike ...
    ... While the overall cost-effectiveness of Medicare benefits have been ... uninsured before receiving benefits at age 65 required ... been privately insured prior to receiving Medicare. These findings, ... the July 12 issue of the New England Journal ...
    Cached Medicine News:Health News:Sun Protection Ignored Despite Warnings 2Health News:Paris Set for Pedal Power Revolution 2Health News:Paris Set for Pedal Power Revolution 3Health News:Uninsured Adults Increase Medicare Costs 2Health News:Uninsured Adults Increase Medicare Costs 3
    ... drainage from the ureteropelvic junction to ... packages. Intended for one-time use. CAUTION: ... Sof-Flex® stents must not remain indwelling ... stents must not remain indwelling more ...
    ... Pigtail Ureteral Stents have an exclusive ... migration. They also feature unique Tecoflex® ... savings. Each Classic Double PigTail Ureteral ... PigTail Ureteral Stent with attached braided ...
    The Needle Loading Platform / Shield is designed to provide superior operator shielding during the loading of prostate implant needles with iodine or palladium seeds. It is constructed of 3/8" alumin...
    The seed alignment tray aligns seeds and spacers for easy access to be picked up by the SeedVac™. It also interfaces with the seed sterilization and sorting tray for protection from radiation....
    Medicine Products: